Press Release 2012

Press Release 2012

Dr. N. Kalyanam, President of Sabinsa's New Jersey R&D, will give a presentation on BioPerine® on June 19, 2012 as part of the SupplySide Science Tour held at the Hyatt Regency Irvine, Irvine, California.

Dr. Kalyanam's presentation will describe BioPerine®, a patented natural extract from Piper nigrum, is a PgP modulator for enhancing bioavailability of nutrients. The presentation will focus on the safety, mechanisms of bioavailability enhancement and will review the results of clinical and other biological studies on this nutrient.

Dr. Kalyanam is the president of Sabinsa's New Jersey R&D. His research interests are synthetic methodology and chiral chemistry. He obtained his masters of science in Chemistry at the University of Madras and doctorate in Organic Chemistry from Baylor University (Texas). Upon completing his Ph.D., Dr. Kalyanam completed two years of postdoctoral studies focusing on organic synthesis procedures before returning to India. In India he worked for a number of reputable companies including IPCL, Ciba Geigy and SPIC Pharma, to which he made major scientific contributions. Dr. Kalyanam's primary responsibilities at Sabinsa include the development of efficient and novel scientific routes for xenobiotics and intermediates as well as the exploration of new business areas.

    VISIT US

  • Sabinsa Europe GmbH
    Monzastrasse 4
    63225 Langen
    Germany

  • +49 6103 270 11 11
  • +49 6103 270 11 27
  • info@sabinsa.eu

CERTIFICATES

Certificate Logos Certificate Logos
Certificate Logos Certificate Logos

CONTACT US

Disclaimer

Please note that this website and information provided herein is not for final consumers of a finished food, beverage, dietary supplement product or cosmetic product, as the information contained herein does not refer to finished products for consumers.

The information provided on the website is intended only for producers of finished food, beverage, dietary supplement and cosmetic product.

The statements related to ingredients on the website, have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease.

The website and information herein are available in various countries across the world, and hence statements or product information including its classification may not be applicable in your country.

Information and statements provided on the website, shall not be construed as license to practice, or recommendations to infringe, any patents or other intellectual property rights of Sabinsa and others.

By browsing further, You understand the above terms.